S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
NYSE:EFX

Equifax (EFX) Stock Price, News & Analysis

$216.20
-1.31 (-0.60%)
(As of 04/19/2024 08:50 PM ET)
Today's Range
$213.06
$218.21
50-Day Range
$216.20
$273.59
52-Week Range
$159.95
$275.10
Volume
2.08 million shs
Average Volume
842,032 shs
Market Capitalization
$26.86 billion
P/E Ratio
48.15
Dividend Yield
0.72%
Price Target
$270.19

Equifax MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.82 Rating Score
Upside/​Downside
25.0% Upside
$270.19 Price Target
Short Interest
Healthy
2.32% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.22mentions of Equifax in the last 14 days
Based on 56 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
31.17%
From $7.38 to $9.68 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.90 out of 5 stars

Business Services Sector

8th out of 300 stocks

Consumer Credit Reporting Agencies, Mercantile Reporting Agencies, Industry

2nd out of 5 stocks

EFX stock logo

About Equifax Stock (NYSE:EFX)

Equifax Inc. operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship. The USIS segment provides consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting services; mortgage services; financial marketing services; identity management services; and credit monitoring products. The International segment offers information service products, which include consumer and commercial services, such as credit and financial information, and credit scoring and modeling; and credit and other marketing products and services, as well as offers information, technology, and other services to support debt collections and recovery management. The company serves customers in financial services, mortgage, retail, telecommunications, utilities, automotive, brokerage, healthcare, and insurance industries, as well as government agencies. It operates in Argentina, Australia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Honduras, India, Ireland, Mexico, New Zealand, Paraguay, Peru, Portugal, Spain, the United Kingdom, Uruguay, and the United States. The company was founded in 1899 and is headquartered in Atlanta, Georgia.

EFX Stock Price History

EFX Stock News Headlines

Equifax (NYSE:EFX) Price Target Cut to $260.00
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Equifax (NYSE:EFX) Price Target Cut to $241.00
Oppenheimer Lowers Equifax (NYSE:EFX) Price Target to $272.00
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Equifax (NYSE:EFX) Shares Gap Down to $237.68
Q1 2024 Equifax Inc Earnings Call
Q1 2024 Equifax Inc Earnings Call Transcript
Why Equifax Stock Is Falling Today
See More Headlines
Receive EFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Equifax and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/15 Dividend
2/22/2024
Dividend Payable
3/15/2024
Last Earnings
4/18/2024
Today
4/22/2024
Next Earnings (Estimated)
7/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Consumer credit reporting agencies, mercantile reporting agencies,
Sub-Industry
Research & Consulting Services
CUSIP
29442910
Employees
14,900
Year Founded
1899

Price Target and Rating

Average Stock Price Target
$270.19
High Stock Price Target
$315.00
Low Stock Price Target
$196.00
Potential Upside/Downside
+25.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.82
Research Coverage
17 Analysts

Profitability

Net Income
$545.30 million
Pretax Margin
13.68%

Debt

Sales & Book Value

Annual Sales
$5.27 billion
Cash Flow
$11.78 per share
Book Value
$36.87 per share

Miscellaneous

Free Float
122,281,000
Market Cap
$26.86 billion
Optionable
Optionable
Beta
1.51

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Should I Buy Equifax Stock? EFX Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Equifax Inc.:

  • Equifax reported strong Q2 earnings, beating the consensus estimate and showing a positive trend in financial performance.
  • Equifax has a solid return on equity of 19.40%, indicating efficient use of shareholder funds to generate profits.
  • Equifax pays a quarterly dividend with a dividend yield of 0.60%, providing investors with a steady income stream.
  • Equifax has received positive analyst ratings, with several analysts upgrading the stock to a "buy" rating, indicating confidence in the company's future growth potential.
  • Equifax's revenue growth of 10.7% year-over-year demonstrates the company's ability to expand its business and increase its market share.

Cons

Investors should be bearish about investing in Equifax Inc. for these reasons:

  • Equifax's stock price has surged to all-time highs, potentially leading to a situation of overvaluation that may pose risks for investors.
  • Equifax's dividend payout ratio (DPR) is relatively high at 35.45%, which could limit the company's ability to reinvest in growth opportunities.
  • Equifax operates in the consumer credit reporting industry, which is subject to regulatory scrutiny and potential legal challenges, adding a level of uncertainty to the investment.
  • Equifax's stock has a high average target price of $264.22, suggesting that the market may have already priced in significant future growth expectations, leaving limited room for further upside.
  • Equifax's business model heavily relies on data, analytics, and technology, making it vulnerable to cybersecurity threats and data breaches, which could damage the company's reputation and financial performance.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, April 13, 2024. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

EFX Stock Analysis - Frequently Asked Questions

Should I buy or sell Equifax stock right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last twelve months. There are currently 3 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EFX shares.
View EFX analyst ratings
or view top-rated stocks.

What is Equifax's stock price target for 2024?

17 Wall Street analysts have issued 1-year target prices for Equifax's stock. Their EFX share price targets range from $196.00 to $315.00. On average, they predict the company's stock price to reach $270.19 in the next year. This suggests a possible upside of 25.0% from the stock's current price.
View analysts price targets for EFX
or view top-rated stocks among Wall Street analysts.

How have EFX shares performed in 2024?

Equifax's stock was trading at $247.29 at the beginning of 2024. Since then, EFX shares have decreased by 12.6% and is now trading at $216.20.
View the best growth stocks for 2024 here
.

Are investors shorting Equifax?

Equifax saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 2,880,000 shares, a drop of 7.7% from the March 15th total of 3,120,000 shares. Based on an average trading volume of 759,400 shares, the days-to-cover ratio is presently 3.8 days.
View Equifax's Short Interest
.

When is Equifax's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 17th 2024.
View our EFX earnings forecast
.

How were Equifax's earnings last quarter?

Equifax Inc. (NYSE:EFX) released its quarterly earnings data on Thursday, April, 18th. The credit services provider reported $1.50 EPS for the quarter, topping analysts' consensus estimates of $1.44 by $0.06. The credit services provider earned $1.39 billion during the quarter, compared to analysts' expectations of $1.40 billion. Equifax had a trailing twelve-month return on equity of 19.08% and a net margin of 10.42%. The business's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.43 earnings per share.
Read the conference call transcript
.

How often does Equifax pay dividends? What is the dividend yield for Equifax?

Equifax declared a quarterly dividend on Wednesday, February 7th. Stockholders of record on Friday, February 23rd will be paid a dividend of $0.39 per share on Friday, March 15th. This represents a $1.56 annualized dividend and a dividend yield of 0.72%. The ex-dividend date is Thursday, February 22nd.
Read our dividend analysis for EFX
.

Is Equifax a good dividend stock?

Equifax (NYSE:EFX) pays an annual dividend of $1.56 per share and currently has a dividend yield of 0.72%. The dividend payout ratio is 34.74%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EFX will have a dividend payout ratio of 16.12% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EFX.

What guidance has Equifax issued on next quarter's earnings?

Equifax updated its second quarter 2024 earnings guidance on Wednesday, April, 17th. The company provided EPS guidance of 1.650-1.750 for the period, compared to the consensus earnings per share estimate of 1.870. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

What is Mark Begor's approval rating as Equifax's CEO?

228 employees have rated Equifax Chief Executive Officer Mark Begor on Glassdoor.com. Mark Begor has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Equifax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Equifax investors own include Hawkins (HWKN), Micron Technology (MU), Mastercard (MA), NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Johnson & Johnson (JNJ), Procter & Gamble (PG), Bank of America (BAC) and Starbucks (SBUX).

Who are Equifax's major shareholders?

Equifax's stock is owned by many different institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.24%), Vaughan Nelson Investment Management L.P. (0.08%), Artemis Investment Management LLP (0.03%), Allen Mooney & Barnes Investment Advisors LLC (0.02%), Brookstone Capital Management (0.02%) and Blue Zone Wealth Advisors LLC (0.02%). Insiders that own company stock include Bryson R Koehler, Carla Chaney, James M Griggs, John W Gamble Jr, Julia A Houston, Julia A Houston, Lisa M Nelson, Mark W Begor, Melissa D Smith, Prasanna Dhore and Sid Singh.
View institutional ownership trends
.

How do I buy shares of Equifax?

Shares of EFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Equifax have any subsidiaries?
The following companies are subsidiares of Equifax: ASNEF/Equifax Servicios de Informacion Sobre Solvencia y Credito S.L., AccountScore, AccountScore Holdings Limited, AccountScore Limited, AccountScore US Corporation, Anakam, Anakam Inc., Anakam Information Solutions LLC, Ansonia Credit Data, Ansonia Credit Data Inc., Apac BizInfo Pte Limited, Appriss Insights, Appriss Insights LLC, Austin Consolidated Holdings Inc., Austin-Tetra, Barnett Associates Operations LLC, Bureau of Credit Histories Equifax Limited Liability Company, CDB Infotek, Compliance Data Center LLC, Computer Ventures Inc., Consents Online Limited, Corporate Services LLC, Credinformacoes Informaçoes de Credito Lda, Creditworks Australia Pty Ltd, Crime Finders LLC, Data-Crédito, DataVision Resources, DataVision Resources LLC, DataX, DataX Ltd., Datalicious Pty Ltd, Datum, EDX Australia Pty Limited, EFX de Costa Rica S.A., Efficient Hire, Equiecua Analytics Services of Risk S.A., Equifax (NZ) Holdings Pty Ltd, Equifax APAC Holdings Limited, Equifax Acquisition Holdings LLC, Equifax Americas S.C.S., Equifax Analytics FZE, Equifax Analytics Private Limited, Equifax Argentina S.A., Equifax Australasia Credit Ratings Pty Limited, Equifax Australasia Group Services Pty Limited, Equifax Australasia HR Solutions Pty Limited, Equifax Australasia Workforce Solutions Pty Limited, Equifax Australia CDR Pty Limited, Equifax Australia Commercial Services and Solutions Pty Limited, Equifax Australia Decision Solutions Pty Limited, Equifax Australia Group Pty Limited, Equifax Australia Holdings Pty Ltd, Equifax Australia Information Services and Solutions Pty Limited, Equifax Australia Marketing Services Pty Limited, Equifax Australia Personal Solutions Pty Limited, Equifax Australia Pty Ltd, Equifax Cambodia Holdings Pte Limited, Equifax Canada Co., Equifax Canadian Holdings II Co., Equifax Centroámerica S.A. de C.V., Equifax Commercial Services Limited, Equifax Consumer Services LLC, Equifax Credit Information Services Private Limited, Equifax Data Services LLC, Equifax EUA Limited, Equifax Ecuador C.A. Buró de Información Crediticia, Equifax Enterprise Services LLC, Equifax Europe LLC, Equifax Fraude S.L., Equifax Funding LLC, Equifax Holdings (NZ) Limited, Equifax Honduras Central de Riesgo Privada S.A., Equifax Iberica S.L., Equifax Information Services LLC, Equifax Information Services of Puerto Rico LLC, Equifax Information Technology LLC, Equifax International Treasury Services Unlimited Company, Equifax Limited, Equifax Luxembourg (No. 10) S.àr.l., Equifax Luxembourg (No. 3) S.àr.l., Equifax New Zealand Holdings Limited, Equifax New Zealand Information Services and Solutions Limited, Equifax Paraguay S.A., Equifax Peru S.A., Equifax Pty Limited, Equifax South America LLC, Equifax Spain Holdings S.àr.l., Equifax Special Services LLC, Equifax Technology (Ireland) Limited, Equifax Technology Solutions LLC, Equifax UK AH Limited, Equifax Uruguay S.A., Equifax do Brasil Ltda., Forseva LLC, GetCreditScore Pty Ltd, Grupo Inffinix S.A. de C.V., HD Information LLC, HIREtech, HealthCare Impact Associates, HealthCare Impact Associates II LLC, HealthCare Impact Associates L.L.C., ID Rehab Holdings Inc., ID Watchdog, IDR Processing LLC, IXI, IXI Corporation, Identity Rehab Corporation, IdentityProtection.com, Inffinix Software, Inffinix Software Comercio Servicios Importação e Expostação Ltda., Inffinix Software S.A. de C.V., Innovative Enterprises LLC, Integrated Debt Services Ltd., IntelliReal, IntelliReal LLC, Inversiones Equifax Chile Limitada, JLR Inc., Knowledge Works Inc., Kount, Kount Inc., Mapcity Peru S.A.C., Mapcity.com Chile S.A., Net Profit Inc., Nevalon Technologies LLC, Paradigm National Consultants LLC, PayNet Inc., Paynet, Pioneer Holdings Limited, Plantation RE Holdings LLC, Rapid Reporting, Rapid Reporting Verification Company LLC, ReachTEL Pty Ltd, Redbird Insurance LLC, Secure Sentinel Australia Pty Limited, Securitec Screening Solutions LLC, Servicios Equifax Chile Limitada, T1 Ventures LLC, TALX Corporation, TALX UCM Services Inc., TDX Group Limited, TDX Indigo Iberia SL, Teletrack, Teletrack LLC, The Prospect Shop Pty Ltd, TrustedID Inc., Typhoon Data LC, VA (NZ) Holdings Limited, VA Australia Finance Pty Limited, Veda Advantage, Verdad Informatica de Costa Rica S.A., Worxtime LLC, ZIP ID Pty Ltd, eThority LLC, ethority, and i2Verify.
Read More
This page (NYSE:EFX) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners